SRT2379

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SRT2379, covering 2017-06-09 to 2017-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Effect of SRT2379 on Endotoxin-Induced Inflammation [Phase 1]